New diabetes treatment enters phase 2 clinical trials
A possible new treatment for type 2 diabetes is about to undergo a phase II clinical trial, offering hope for sufferers. Image Credit Volunteers enrolled Ligand Pharmaceuticals’ LGD-6972 molecule is set to enter the phase II clinical trial and will … read more